Psychiatric Issues in Multiple Sclerosis
Open accessAbstract
MDD and anxiety disorders are highly prevalent among persons who have MS and have been associated with decreased adherence to MS treatment and poorer functional status and quality of life. Effective treatment is available for MDD, but this disorder continues to be underdetected and undertreated by MS providers. Treatment with pharmacotherapy is particularly challenging in this patient population, given the somatic symptom overlap between MS and depression and the increased burden of side effects. Larger randomized, controlled trials are needed to elucidate further the effectiveness of pharmacotherapy and to identify subgroups of patients who would benefit from this type of treatment for depression. There have been few rigorous studies of the prevalence and impact of anxiety disorders, substance use disorders, or serious mental illness such as bipolar disorder or schizophrenia, in MS samples.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Symptoms of anxiety and depression are common in multiple sclerosis and are linked to social dysfunction, decreased adherence to treatment, somatic complaints and lower functional status.
“Symptoms of anxiety and depression are common, and linked to social dysfunction, decreased adherence to treatment, somatic complaints and lower functional status (1).”
From Cognitive behavioural therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy (2012) · cites this paper as [1]
The Summary and Overview describe depression and anxiety as common in people with MS and associate them with decreased treatment adherence and poorer functional status. The Impact section also describes disruption of social support and family systems among patients with depression. The paper discusses overlap between MS and depression in somatic symptoms, but does not establish the claimed link to somatic complaints. (LLM, conf=0.88)
Experimental — accuracy not yet measuredDepression and anxiety appear to be undertreated in multiple sclerosis outpatient settings.
“The importance of continued research in this field is illus -trated by studies suggesting that depression and anxiety appear to be undertreated in MS outpatient settings (1).”
From Cognitive behavioural therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy (2012) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370 · see citing works
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988 · see citing works
The posttraumatic growth inventory: measuring the positive legacy of trauma
Tedeschi, R. G., & Calhoun, L. G. (1996) · Journal of Traumatic Stress · doi:10.1002/jts.2490090305 · Cited by 7,061 · cited 1× · see citing works
“[96] It is thought to involve more than resilience, namely, growth and improved functioning beyond a return to a pre-event level of psychological functioning.”
BackgroundBonanno, G. A. (2004) · American Psychologist · doi:10.1037/0003-066x.59.1.20 · Cited by 6,851 · see citing works
Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,648 · see citing works
The CAGE Questionnaire: Validation of a New Alcoholism Screening Instrument
Mayfield, D. G., McLeod, G. A., & Hall, P. B. (1974) · American Journal of Psychiatry · doi:10.1176/ajp.131.10.1121 · Cited by 2,261 · see citing works
Utility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.1994.03520220043029 · Cited by 1,873 · see citing works
Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population
Perälä, J., Suvisaari, J., Saarni, S. I., Kuoppasalmi, K. I., Isometsä, E. T., Pirkola, S. P., Partonen, T., Tuulio‐Henriksson, A., Hintikka, J., Kieseppä, T., et al. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.1.19 · Cited by 1,523 · see citing works
Effects of exercise training on older patients with major depression
Blumenthal, J. A., Babyak, M. A., Moore, K. A., Craighead, W. E., Herman, S., Khatri, P., Waugh, R., Napolitano, M. A., Forman, L. M., Appelbaum, M., et al. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.19.2349 · Cited by 1,277 · see citing works
Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months
Babyak, M., Blumenthal, J. A., Herman, S., Khatri, P., Doraiswamy, M., Moore, K., Edward Craighead, W., Baldewicz, T. T., & Ranga Krishnan, K. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200009000-00006 · Cited by 1,063 · see citing works
Broadening the base of treatment for alcohol problems
Hertzman, M. (1991) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(91)90057-h · Cited by 832 · see citing works
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827 · see citing works
Impact of aerobic training on fitness and quality of life in multiple sclerosis
Petajan, J. H., Gappmaier, E., White, A. T., SPENCER, M. K., Mino, L., & Hicks, R. W. (1996) · Annals of Neurology · doi:10.1002/ana.410390405 · Cited by 756 · see citing works
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555 · see citing works
Self-citationFleming, M. F. (1997) · JAMA · doi:10.1001/jama.1997.03540370029032 · Cited by 538 · see citing works
Major depression in multiple sclerosis
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095964.34294.b4 · Cited by 530 · see citing works
Steroid-induced psychiatric syndromes
Lewis, D. A., & Smith, R. E. (1983) · Journal of Affective Disorders · doi:10.1016/0165-0327(83)90022-8 · Cited by 528 · see citing works
Quality of life in multiple sclerosis: the impact of depression, fatigue and disability
Amato, M. P., Ponziani, G., Rossi, F., Liedl, C. L., Stefanile, C., & Rossi, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700511 · Cited by 506 · see citing works
Psychiatric and Medical Comorbidities of Bipolar Disorder
Krishnan, K. R. R. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000151489.36347.18 · Cited by 502 · see citing works
The prevalence and impact of alcohol problems in major depression: A systematic review
Sullivan, L. E., Fiellin, D. A., & O’Connor, P. G. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.007 · Cited by 489 · see citing works
Anxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424 · see citing works
Cause of death in patients attending multiple sclerosis clinics
Sadovnick, A. D., Eisen, K., Ebers, G. C., & Paty, D. W. (1991) · Neurology · doi:10.1212/wnl.41.8.1193 · Cited by 401 · see citing works
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis
Mohr, D. C., Hart, S. L., Julian, L., Cox, D., & Pelletier, D. (2004) · BMJ · doi:10.1136/bmj.38041.724421.55 · Cited by 401 · see citing works
National Household Survey on Drug Abuse: Main Findings 1998
(2000) · PsycEXTRA Dataset · doi:10.1037/e442572005-001 · Cited by 396 · see citing works
The epidemiology of generalized anxiety disorder
Kessler, R. C., Keller, M. B., & Wittchen, H.-U. (2001) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70204-5 · Cited by 337 · see citing works
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334 · see citing works
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1162oa · Cited by 329 · cited 4× · see citing works
“This epidemiological research led an expert consensus panel to conclude that the single most useful step that can be taken with regard to the primary prevention of suicide in MS is better identification and treatment of depressive disorders [12].”
BackgroundInfluentialAn examination of suicidal intent in patients with multiple sclerosis
Feinstein, A. (2002) · Neurology · doi:10.1212/wnl.59.5.674 · Cited by 326 · see citing works
Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple Sclerosis
Mohr, D. C., Goodkin, D., Likosky, W., Gatto, N. M., Baumann, K. A., & Rudick, R. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170015009 · Cited by 306 · see citing works
Telephone-administered psychotherapy for depression
Mohr, D. C., Hart, S. L., Julian, L., Catledge, C., Honos-Webb, L., Vella, L., & Tasch, E. T. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.1007 · Cited by 298 · see citing works
Factors related to employment status changes in individuals with multiple sclerosis
Smith, M., & Arnett, P. A. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1204oa · Cited by 269 · see citing works
Prospective Study of Physical Activity and Depressive Symptoms in Middle-Aged Women
BROWN, W., FORD, J., BURTON, N., MARSHALL, A., & DOBSON, A. (2005) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.06.009 · Cited by 269 · see citing works
Depression in multiple sclerosis.
Minden, S., Orav, J., & Reich, P. (1987) · General Hospital Psychiatry · doi:10.1016/0163-8343(87)90052-1 · Cited by 267 · see citing works
Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects
Zorzon, M., de Masi, R., Nasuelli, D., Ukmar, M., Pozzi Mucelli, R., Cazzato, G., Bratina, A., & Zivadinov, R. (2001) · Journal of Neurology · doi:10.1007/s004150170184 · Cited by 249 · cited 2× · see citing works
“[37] Some studies have found associations between depression and severity of MS as reflected by degree of disability [38], but other studies have not replicated these findings.”
ResultMohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Wende, J. V. D., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.2.356 · Cited by 240 · see citing works
Treatment of Pathologic Laughing and Weeping with Amitriptyline
Schiffer, R. B., Herndon, R. M., & Rudick, R. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122303 · Cited by 234 · see citing works
Brain MRI lesions and atrophy are related to depression in multiple sclerosis
Bakshi, R., Czarnecki, D., Shaikh, Z. A., Priore, R. L., Janardhan, V., Kaliszky, Z., & Kinkel, P. R. (2000) · Neuroreport · doi:10.1097/00001756-200004270-00003 · Cited by 230 · see citing works
Naber, D., Sand, P. G., & Heigl, B. (1996) · Psychoneuroendocrinology · doi:10.1016/0306-4530(95)00031-3 · Cited by 223 · see citing works
The Epidemiology of Multiple Sclerosis
Hogancamp, W. E., Rodriguez, M., & Weinshenker, B. G. (1997) · Mayo Clinic Proceedings · doi:10.4065/72.9.871 · Cited by 222 · see citing works
Suicide and multiple sclerosis: an epidemiological investigation.
Stenager, E., Stenager, E., Koch–Henriksen, N., Brønnum‐Hansen, H., Hyllested, K., Jensen, K., & Bille‐Brahe, U. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.7.542 · Cited by 218 · see citing works
Janssens, A. C. J. W., van Doorn, P. A., de Boer, J. B., Kalkers, N. F., van der Meché, F. G. A., Passchier, J., & Hintzen, R. Q. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms930oa · Cited by 209 · see citing works
Antidepressant pharmacotherapy of depression associated with multiple sclerosis
Schiffer, R. B., & WINEMAN, N. M. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.11.1493 · Cited by 200 · see citing works
Sirois, F. J. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00241-4 · Cited by 197 · see citing works
Cognitive functioning in sober social drinkers: a review of the research since 1986.
Parsons, O. A., & Nixon, S. J. (1998) · Journal of Studies on Alcohol · doi:10.15288/jsa.1998.59.180 · Cited by 196 · see citing works
Edwards, L. J., & Constantinescu, C. S. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1087oa · Cited by 194 · see citing works
Prevalence and Neurobehavioral Correlates of Pathological Laughing and Crying in Multiple Sclerosis
Feinstein, A., Feinstein, K., Gray, T., & O'Connor, P. W. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210050012 · Cited by 189 · see citing works
Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis
Möller, A. A., Wiedemann, G., Rohde, U., Backmund, H., & Sonntag, A. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01497.x · Cited by 186 · see citing works
PANITCH, H. S., Thisted, R. A., Smith, R. A., Wynn, D. R., Wymer, J. P., Achiron, A., Vollmer, T. L., Mandler, R. N., Dietrich, D. W., Fletcher, M., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20828 · Cited by 174 · see citing works
Corticosteroid-Induced Adverse Psychiatric Effects
Patten, S. B., & Neutel, C. I. (2000) · Drug Safety · doi:10.2165/00002018-200022020-00004 · Cited by 172 · see citing works
Management of patients receiving interferon beta-1b for multiple sclerosis
LUBLIN, F. D., Whitaker, J. N., Eidelman, B. H., Miller, A., Arnason, B. G. W., & BURKS, J. S. (1996) · Neurology · doi:10.1212/wnl.46.1.12 · Cited by 169 · see citing works
Association between bipolar affective disorder and multiple sclerosis
Schiffer, R. B., WINEMAN, N. M., & WEITKAMP, L. R. (1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.1.94 · Cited by 167 · see citing works
Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population
Patten, S. B., Metz, L. M., & Reimer, M. A. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600210 · Cited by 166 · see citing works
Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis
Pujol, J., Bello, J., Deus, J., Martí-Vilalta, J. L., & Capdevila, A. (1997) · Neurology · doi:10.1212/wnl.49.4.1105 · Cited by 159 · see citing works
Treatment of depression in multiple sclerosis: Review and meta-analysis.
Mohr, D. C., & Goodkin, D. E. (1999) · Clinical Psychology: Science and Practice · doi:10.1093/clipsy.6.1.1 · Cited by 155 · see citing works
Patterns of cannabis use among patients with multiple sclerosis
Clark, A. J., Ware, M. A., Yazer, E., Murray, T. J., & Lynch, M. E. (2004) · Neurology · doi:10.1212/01.wnl.0000127707.07621.72 · Cited by 153 · see citing works
Increased Depression in Multiple Sclerosis Patients
Schubert, D. S. P., & Foliart, R. H. (1993) · Psychosomatics · doi:10.1016/s0033-3182(93)71902-7 · Cited by 151 · see citing works
Cost and health related quality of life consequences of multiple sclerosis
Grima, D. T., Torrance, G. W., Francis, G., Rice, G. P. A., Rosner, A., & Lafortune, L. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600207 · Cited by 151 · see citing works
Mood Changes During Prednisone Bursts in Outpatients With Asthma
Brown, E. S., Suppes, T. M., Khan, D. A., & Carmody, T. J. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00009 · Cited by 151 · see citing works
Pathologic Laughing and Crying Treated With Levodopa
Udaka, F., Yamao, S., Nagata, H., Nakamura, S., & Kameyama, M. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050210093023 · Cited by 151 · see citing works
Side effect profile of interferon beta-lb in MS
Neilley, L. K., Goodin, D. S., Goodkin, D. E., & Hauser, S. L. (1996) · Neurology · doi:10.1212/wnl.46.2.552 · Cited by 150 · see citing works
Low-risk Drinking Guidelines: The Scientific Evidence
Bondy, S. J., Rehm, J. T., Ashley, M. J., WALSH, G. W., Single, E. W., & Room, R. (1999) · Canadian Journal of Public Health · doi:10.1007/bf03404129 · Cited by 150 · see citing works
The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis
Feinstein, A., O'Connor, P., Gray, T., & Feinstein, K. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500504 · Cited by 147 · see citing works
Physical activity and depression: clinical experience
Martinsen, E. W. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb05797.x · Cited by 145 · see citing works
Depression, cognitive impairment and social stress in multiple sclerosis
Gilchrist, A., & Creed, F. H. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90115-5 · Cited by 127 · see citing works
Treatment of depression for patients with multiple sclerosis in neurology clinics
Mohr, D. C., Hart, S. L., Fonareva, I., & Tasch, E. S. (2006) · Multiple Sclerosis Journal · doi:10.1191/135248506ms1265oa · Cited by 126 · see citing works
Galeazzi, G., Ferrari, S., Giaroli, G., Mackinnon, A., Merelli, E., Motti, L., & Rigatelli, M. (2005) · Neurological Sciences · doi:10.1007/s10072-005-0468-8 · Cited by 126 · see citing works
Lesion pattern in patients with multiple sclerosis and depression
Berg, D., Supprian, T., Thomae, J., Warmuth‐Metz, M., Horowski, A., Zeiler, B., Magnus, T. U., Rieckmann, P., & Becker, G. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600304 · Cited by 113 · see citing works
Julian, L. J., Merluzzi, N., & Mohr, D. C. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070255 · Cited by 110 · see citing works
Screening for depression among patients with multiple sclerosis: two questions may be enough
Mohr, D. C., Hart, S., Julian, L. J., & Tasch, E. S. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506070926 · Cited by 105 · see citing works
Multiple Sclerosis, interferon beta-1b and depression
Feinstein, A., O’Connor, P., & Feinstein, K. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0725-0 · Cited by 103 · see citing works
Psychiatric Side Effects of Steroid Therapy
Kershner, P., & Wang-Cheng, R. M. (1989) · Psychosomatics · doi:10.1016/s0033-3182(89)72293-3 · Cited by 100 · see citing works
Cannabis use in patients with multiple sclerosis
Chong, M. S., Wolff, K., Wise, K., Tanton, C., WINSTOCK, A. R., & Silber, E. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458506070947 · Cited by 100 · see citing works
Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis
Minden, S. L., Orav, J., & Schildkraut, J. J. (1988) · Neurology · doi:10.1212/wnl.38.10.1631 · Cited by 93 · see citing works
Adrenal Size Is Increased in Multiple Sclerosis
Reder, A. T., Makowiec, R. L., & Lowy, M. T. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540140057015 · Cited by 89 · see citing works
Alcohol and drug abuse among persons with multiple sclerosis
Bombardier, C., Blake, K., Ehde, D., Gibbons, L., Moore, D., & Kraft, G. (2004) · Multiple Sclerosis · doi:10.1191/1352458504ms989oa · Cited by 89 · see citing works
Self-citationTreatment of Depression in Primary Care
Katon, W. J., Un??tzer, J., & Simon, G. E. (2004) · Medical Care · doi:10.1097/00005650-200412000-00001 · Cited by 86 · see citing works
Multiple sclerosis, depression, and suicide
Feinstein, A. (1997) · BMJ · doi:10.1136/bmj.315.7110.691 · Cited by 82 · see citing works
Interferon β1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial
Patten, S. B., & Metz, L. M. (2002) · Neurology · doi:10.1212/wnl.59.5.744 · Cited by 82 · see citing works
Tsivgoulis, G., Triantafyllou, N., Papageorgiou, C., Evangelopoulos, M., Kararizou, E., Sfagos, C., & Vassilopoulos, D. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00736.x · Cited by 77 · see citing works
Mood disorders in multiple sclerosis: diagnosis and treatment.
Minden, S. L. (2000) · PubMed · Cited by 77 · see citing works
Multiple sclerosis and depression: influence of interferon b therapy
Zéphir, H., Seze, J. D., Stojkovic, T., Delisse, B., Ferriby, D., Cabaret, M., & Vermersch, P. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms915oa · Cited by 73 · see citing works
Multiple sclerosis, disease modifying treatments and depression: a critical methodological review
Feinstein, A. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600509 · Cited by 69 · see citing works
Course of Depression During the Initiation of Interferon Beta-1a Treatment for Multiple Sclerosis
Mohr, D. C., Likosky, W., Dwyer, P., Wende, J. V. D., Boudewyn, A. C., & Goodkin, D. (1999) · Archives of Neurology · doi:10.1001/archneur.56.10.1263 · Cited by 68 · see citing works
Rapidly cycling bipolar disorder and multiple sclerosis
Kellner, C. H., Davenport, Y. B., Post, R. M., & Ross, R. J. (1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.1.112 · Cited by 67 · see citing works
Depression before and after diagnosis of multiple sclerosis
Sullivan, M. J. L., Weinshenker, B. G., Mikail, S. F., & Edgley, K. (1995) · Multiple Sclerosis Journal · doi:10.1177/135245859500100208 · Cited by 63 · see citing works
Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample
Cetin, K., Johnson, K. L., Ehde, D. M., Kuehn, C. M., Amtmann, D., & Kraft, G. H. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458507077864 · Cited by 58 · see citing works
Self-citationPatients with multiple sclerosis presenting to psychiatric hospitals.
Pine, D. S., Douglas, C. J., Charles, E., Davies, M., & Kahn, D. A. (1995) · PubMed · Cited by 55 · see citing works
Risk Factors for Suicide in Multiple Sclerosis
Stenager, E. N., Koch‐Henriksen, N., & Stenager, E. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289052 · Cited by 52 · see citing works
Multiple sclerosis and alcohol: a study of problem drinking
Quesnel, S., & Feinstein, A. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms992oa · Cited by 52 · see citing works
Hospital-based Psychiatric Service Utilization and Morbidity in Multiple Sclerosis
Fisk, J. D., Morehouse, S. A., Brown, M. G., Skedgel, C. D., & Murray, T. J. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034065 · Cited by 48 · see citing works
Multiple Sclerosis: The Guide to Treatment and Management
Polman, C. H. (2001) · Cited by 40 · see citing works
Prevalence and Risk Factors of Illicit Drug Use by People With Disabilities
Moore, D., & Li, L. (1998) · American Journal on Addictions · doi:10.1111/j.1521-0391.1998.tb00324.x · Cited by 38 · see citing works
Serotonin, fluoxetine, and pseudobulbar affect
Seliger, G. M., & Hornstein, A. (1989) · Neurology · doi:10.1212/wnl.39.10.1400 · Cited by 27 · see citing works
Case Study: Mania Associated with Multiple Sclerosis
Heilä, H., Turpeinen, P., & Erkinjuntti, T. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199512000-00009 · Cited by 24 · see citing works
(1996) · Multiple Sclerosis Journal · doi:10.1177/135245859600100508 · Cited by 24 · see citing works
Mania as a symptom of multiple sclerosis
Kwentus, J. A., Hart, R. P., Calabrese, V. P., & Hekmati, A. (1986) · Psychosomatics · doi:10.1016/s0033-3182(86)72623-6 · Cited by 19 · see citing works
Marijuana and multiple sclerosis
Goodin, D. S. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00655-0 · Cited by 12 · see citing works
Salmaggi, A., Eoli, M., Mantia, L. L., & Erbetta, A. (1995) · The Italian Journal of Neurological Sciences · doi:10.1007/bf02282913 · Cited by 8 · see citing works
Skorin, L. (1995) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.1995.95.9.558a · Cited by 3 · see citing works
Mood Disorders and Dysfunction of the Hypothalamic-Pituitary-Adrenal Axis in Multiple Sclerosis
Fassbender, K. C., Schmidt, R., Mößner, R., Kischka, U., Kühnen, J., Schwartz, A., & Hennerici, M. G. (1998) · Archives of Neurology · doi:10.1001/archneur.55.1.66
Flagged first, then by citations
1 of the 101 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [79]First MB, Spitzer RL, Gibbon M, et al. Structured clinical interview for Axis I DSM-IV disorders—patient edition, SCID-i/p, Version 2.0. New York: State Psychiatric Institute; 1994. [Google Scholar]
- [84]Fleming M, Barry K, Manwell L, et al. Brief physician advice for problem alcohol drinkers. J Am Med Assoc. 1997;277:1039–1045. [PubMed] [Google Scholar]
Cited by
Sorted by citations
Mindfulness based interventions in multiple sclerosis–a systematic review
Simpson, R., Booth, J., Lawrence, M., Byrne, S., Mair, F., & Mercer, S. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-15 · Cited by 195 · see citing works
A putative functional role for oligodendrocytes in mood regulation
Edgar, N. M., & Sibille, E. L. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.34 · Cited by 186 · see citing works
Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art
Silveira, C., Guedes, R., Maia, D., Curral, R., & Coelho, R. C. (2019) · Psychiatry Investigation · doi:10.30773/pi.2019.0106 · Cited by 181 · see citing works
Neuropsychiatric syndromes of multiple sclerosis
Murphy, R., O’Donoghue, S., Counihan, T. J., McDonald, C., Calabresi, P. A., Ahmed, M. A., Kaplin, A. I., & Hallahan, B. P. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-315367 · Cited by 170 · see citing works
Konradi, C. L., Daws, S. E., & Clay, H. B. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.025 · Cited by 148 · see citing works
Comorbidities amongst patients with multiple sclerosis: a population‐based controlled study
Kang, J., Chen, Y. ‐., & Lin, H.-C. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02971.x · Cited by 132 · see citing works
Depressogenic effects of medications: a review
Celano, C. M., Freudenreich, O., Fernandez-Robles, C. G., Stern, T. A., Caro, M. A., & Huffman, J. C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/ccelano · Cited by 116 · see citing works
Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?
McNamara, R. K., & Lotrich, F. E. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.98 · Cited by 109 · see citing works
Nordin, L., & Rorsman, I. (2012) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0898 · Cited by 106 · see citing works
Resilience and Stuttering: Factors That Protect People From the Adversity of Chronic Stuttering
Craig, A. R., Blumgart, E., & Tran, Y. (2011) · Journal of Speech Language and Hearing Research · doi:10.1044/1092-4388(2011/10-0304 · Cited by 100 · see citing works
Henry, A., Tourbah, A., Camus, G., Deschamps, R., Mailhan, L., Castex, C., Gout, O., & Montreuil, M. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.09.039 · Cited by 95 · see citing works
Social Cognition Impairments in Relapsing-Remitting Multiple Sclerosis
Henry, A., Tourbah, A., Chaunu, M., Rumbach, L., Montreuil, M., & Bakchine, S. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617711001147 · Cited by 89 · see citing works
Kallaur, A. P., Lopes, J. M., Oliveira, S. R., Simão, A. N. C., Reiche, E. M. V., de Almeida, E. R. D., Morimoto, H. K., de Pereira, W. L. C. J., Alfieri, D. F., Borelli, S. D., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9443-4 · Cited by 82 · see citing works
Symptomatic Management in Multiple Sclerosis
Samkoff, L., & Goodman, A. D. (2011) · Neurologic Clinics · doi:10.1016/j.ncl.2011.01.008 · Cited by 80 · see citing works
Resting State Brain Entropy Alterations in Relapsing Remitting Multiple Sclerosis
Zhou, F., Zhuang, Y., Gong, H., Zhan, J., Grossman, M., & Wang, Z. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146080 · Cited by 76 · see citing works
Restless legs syndrome in multiple sclerosis
Siemiński, M., Losy, J., & Partinen, M. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.10.002 · Cited by 71 · see citing works
Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis
Miller, E. D., Morel, A., Redlicka, J., Miller, I., & Saluk, J. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171109132650 · Cited by 69 · see citing works
Myelin copper and the cuprizone model of schizophrenia
Konradi, C. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s129 · Cited by 67 · see citing works
Cognitive and neurobehavioral features in multiple sclerosis
Arnett, P. A., & Strober, L. B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.12 · Cited by 59 · see citing works
Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura
Falter, T., Schmitt, V., Herold, S., Weyer, V., von Auer, C., Wagner, S., Hefner, G., Beutel, M. E., Lackner, K. J., Lämmle, B., et al. (2017) · Transfusion · doi:10.1111/trf.14060 · Cited by 58 · see citing works
Simpson, R., McLean, G., Guthrie, B., Mair, F. S., & Mercer, S. W. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-128 · Cited by 54 · see citing works
Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review
Bove, R. M., Okai, A. F., Houtchens, M. K., Elias-Hamp, B., Lugaresi, A., Hellwig, K., & Havrdová, E. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.554375 · Cited by 51 · see citing works
Barriers to quality of life in patients with multiple sclerosis: a qualitative study
Hosseini, Z., Homayuni, A., & Etemadifar, M. (2022) · BMC Neurology · doi:10.1186/s12883-022-02700-7 · Cited by 50 · see citing works
Restless Legs Syndrome in Multiple Sclerosis
Aydar, G., Kurt, S. G., Ünaldı, H. K., & Erkorkmaz, Ü. (2011) · European Neurology · doi:10.1159/000327315 · Cited by 51 · see citing works
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial
Schippling, S., O'Connor, P. W., Knappertz, V. A., Pohl, C., Bogumil, T., Suarez, G., Cook, S. D., Filippi, M., Hartung, H.-P., Comı, G., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8146-8 · Cited by 49 · see citing works
Resilience in People with Physical Disabilities
Craig, A. R. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780199733989.013.0026 · Cited by 48 · see citing works
Quality of life and coping strategies in Lebanese multiple sclerosis patients: a pilot study
Farran, N., Ammar, D., & Darwish, H. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.12.003 · Cited by 42 · see citing works
Saunders, C., Caon, C., Smrtka, J., & Shoemaker, J. (2010) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3181ee122b · Cited by 45 · see citing works
Personality characteristics and disorders in multiple sclerosis patients: Assessment and treatment
Stathopoulou, A., Christopoulos, P., Soubasi, E., & Gourzis, P. (2010) · International Review of Psychiatry · doi:10.3109/09540261003589349 · Cited by 40 · see citing works
Edgar, N. M., Touma, C., Palme, R., & Sibille, E. L. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.40 · Cited by 41 · see citing works
The Relationship of Age-Related Factors to Psychological Functioning Among People With Disabilities
Bombardier, C. H., Ehde, D. M., Stoelb, B. L., & Molton, I. R. (2010) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2009.12.005 · Cited by 39 · see citing works
Self-citationAlcohol and substance use in multiple sclerosis
Beier, M. L., D’Orio, V. L., Spat‐Lemus, J., Shuman, M. A., & Foley, F. W. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.12.029 · Cited by 36 · see citing works
Oliveira, S. R., Kallaur, A. P., Lopes, J. M., Simão, A. N. C., Reiche, E. M. V., de Almeida, E. R. D., Morimoto, H. K., Pereira, W. L. D. C. J., Alfieri, D. F., Flauzino, T., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.039 · Cited by 37 · see citing works
Newland, P., Naismith, R. T., & Ullione, M. (2009) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3181b6be96 · Cited by 35 · see citing works
Psychiatric Comorbidity in Pediatric Patients With Demyelinating Disorders
Weisbrot, D. M., Ettinger, A. B., Gadow, K. D., Belman, A. L., MacAllister, W. S., Milazzo, M. C., Reed, M. L., Serrano, D., & Krupp, L. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338519 · Cited by 32 · see citing works
Marchese, E., Valentini, M., Sante, G. D., Cesari, E., Adinolfi, A., Corvino, V., Ria, F., Sette, C., & Geloso, M. C. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113497 · Cited by 29 · see citing works
Menopause in multiple sclerosis: therapeutic considerations
Bove, R. M., Chitnis, T., & Houtchens, M. K. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7131-8 · Cited by 27 · see citing works
Ayache, S. S., & Chalah, M. A. (2018) · Neurodegenerative Disease Management · doi:10.2217/nmt-2018-0028 · Cited by 26 · see citing works
Caneo, C., Marston, L., Bellón, J. Á., & King, M. (2016) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2016.09.007 · Cited by 26 · see citing works
Seyedsaadat, S. M., Hosseininezhad, M., Bakhshayesh, B., Saadat, S. N. S., & Sp, N. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1593-4 · Cited by 24 · see citing works
Cuprizone-induced demyelination in the mouse hippocampus is alleviated by phytoestrogen genistein
Ohgomori, T., & Jinno, S. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.11.009 · Cited by 23 · see citing works
Progressive multiple sclerosis and mood disorders
Lorefice, L., Fenu, G., Trincas, G., Moro, M., Frau, J., Coghe, G., Cocco, E., Marrosu, M., & Carta, M. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2220-3 · Cited by 17 · see citing works
Quality of life in patients with multiple sclerosis in Eastern Slovakia
Szilasiová, J., Krokavcova, M., Gdovinová, Z., Rosenberger, J., & van Dijk, J. V. (2011) · Disability and Rehabilitation · doi:10.3109/09638288.2010.540292 · Cited by 27 · see citing works
Beratto, L., Bressy, L., Agostino, S., Malandrone, F., Brichetto, G., & Ponzano, M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105473 · Cited by 20 · see citing works
Tauheed, A. M., Ayo, J. O., & Kawu, M. U. (2016) · Pathophysiology · doi:10.1016/j.pathophys.2016.05.007 · Cited by 20 · see citing works
Homayuni, A., Abedini, S., Hosseini, Z., Etemadifar, M., & Ghanbarnejad, A. (2021) · BMC Neurology · doi:10.1186/s12883-021-02213-9 · Cited by 20 · see citing works
Pharmacological management of depression in patients with multiple sclerosis
Carta, M. G., Paribello, P., Anastasia, A., Berardis, D. D., Nardi, A. E., & Fornaro, M. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1516207 · Cited by 21 · see citing works
Kupferman, A., & Leibowitz, H. M. (1975) · PubMed · Cited by 20 · see citing works
The emotional disorders associated with multiple sclerosis.
Raimo, S., Santangelo, G., & Trojano, L. (2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-822290-4.00009-8 · Cited by 19 · see citing works
Jun-O’connell, A., Butala, A., Morales, I., Henninger, N., Deligiannidis, K., Byatt, N., & Ionete, C. (2016) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/appi.neuropsych.15120403 · Cited by 19 · see citing works
Cognitive impairment in multiple sclerosis: “classic” knowledge and recent acquisitions
Piacentini, C., Argento, O., & Nocentini, U. (2023) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0043-1763485 · Cited by 18 · see citing works
Abundance of Stress, Anxiety and Depression in Multiple Sclerosis Patients
Dehghan, A., کرمانشاهی, S. م., Kermanshahi, M., & Memarian, R. (2013) · Alborz University Medical Journal · doi:10.18869/acadpub.aums.2.2.82 · Cited by 18 · see citing works
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran
Mohammadi, K., Rahnama, P., & Montazeri, A. (2015) · Annals of General Psychiatry · doi:10.1186/s12991-015-0069-8 · Cited by 18 · see citing works
Faraclas, E. (2023) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s395733 · Cited by 17 · see citing works
Examining the Role of Resilience and Hope in Grit in Multiple Sclerosis
Lee, B., Rumrill, P. D., & Tansey, T. N. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.875133 · Cited by 16 · see citing works
Pulse steroid therapy in multiple sclerosis and mood changes: An exploratory prospective study
Lorefice, L., Fenu, G., Fois, M., Frau, J., Coghe, G., Marrosu, M. G., & Cocco, E. E. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.01.012 · Cited by 16 · see citing works
Zhang, T., Kingwell, E., de Jong, H. J. I., Zhu, F., Zhao, Y., Carruthers, R. L., Petkau, J., Gustafson, P., Oger, J., & Tremlett, H. L. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4031 · Cited by 15 · see citing works
Kalron, A., & Aloni, R. (2017) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2017.10.012 · Cited by 15 · see citing works
Posttraumatic stress disorder symptoms in individuals with multiple sclerosis.
Counsell, A., Hadjistavropoulos, H. D., Kehler, M. D., & Asmundson, G. J. G. (2012) · Psychological Trauma Theory Research Practice and Policy · doi:10.1037/a0029338 · Cited by 15 · see citing works
Behavioral Neurology of Multiple Sclerosis and Autoimmune Encephalopathies.
Moghadasi, A., Pourmand, S., Sharifian, M., Minagar, A., & Sahraian, M. (2016) · Neurologic clinics · doi:10.1016/j.ncl.2015.08.002 · Cited by 13 · see citing works
Shafiee, A., Soltani, H., Athar, M. M. T., Jafarabady, K., & Mardi, P. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104922 · Cited by 13 · see citing works
van Ballegooijen, H., van der Hiele, K., Enzinger, C., de Voer, G., & Visser, L. H. (2022) · eNeurologicalSci · doi:10.1016/j.ensci.2022.100409 · Cited by 13 · see citing works
Farmani, F., Taghavi, H. R., Fatemi, A., & Safavi, S. R. (2015) · International Journal of Applied Behavioral Sciences · doi:10.22037/ijabs.v2i4.11421 · Cited by 13 · see citing works
Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study
Lorefice, L., Fenu, G., Carta, E., Frau, J., Coghe, G., Contu, F., Barracciu, M. A., Carta, M. G., & Cocco, E. E. (2020) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2020.102564 · Cited by 12 · see citing works
Physical and Mental Health Comorbidities Among Adults With Multiple Sclerosis
Peterson, M. D., Lin, P., Kamdar, N. S., Marsack‐Topolewski, C. N., & Mahmoudi, E. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.11.004 · Cited by 12 · see citing works
Jones, J., Walsh, S., & Isaac, C. L. (2014) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-014-9408-1 · Cited by 11 · see citing works
Managing Disability in Progressive Multiple Sclerosis
Dubey, D., Sguigna, P. V., & Stüve, O. (2016) · Current Treatment Options in Neurology · doi:10.1007/s11940-016-0412-7 · Cited by 10 · see citing works
Neuroimmune, clinical and treatment challenges in multiple sclerosis-related psychoses
Vesić, K., Gavrilović, A., Mijailović, N. R., & Borovčanin, M. (2023) · World Journal of Psychiatry · doi:10.5498/wjp.v13.i4.161 · Cited by 9 · see citing works
Al-Hussain, F., Al-Salloum, N., Alazwary, N., Saeedi, J., Howaidi, S., & Daif, A. (2017) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2016-0087 · Cited by 9 · see citing works
Psychotherapie in der neurologischen Rehabilitation
Schmidt, R., Piliavska, K., Maier-Ring, D., van Husen, D. K., & Dettmers, C. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-104525 · Cited by 9 · see citing works
Manic Episodes Due to Medical Illnesses
Torales, J. C., González, I., Barrios, I., Ventriglio, A., & Bhugra, D. (2018) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000875 · Cited by 8 · see citing works
Khader, H. A., Emran, B., Sulaimi, M. A., Abdulhadi, D. A., Obaidli, K. A., Deai, A. A., & Albatineh, A. N. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2019.101391 · Cited by 8 · see citing works
Predictors of changes in suicidality in multiple sclerosis over time
Flood, S., Foley, F. W., Zemon, V. M., Picone, M., Bongardino, M., & Quinn, H. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2013.822570 · Cited by 8 · see citing works
Mansourzadeh, A., Shaygannejad, V., Mirmosayyeb, O., Afshari-Safavi, A., & Gay, M. (2023) · Middle East Journal of Rehabilitation and Health Studies · doi:10.5812/mejrh-132571 · Cited by 7 · see citing works
Leonavičius, R., Adomaitienė, V., & Leskauskas, D. (2011) · Open Medicine · doi:10.2478/s11536-011-0059-4 · Cited by 6 · see citing works
Preventing suicidal behavior in patients with multiple sclerosis: a scoping review
Mellentin, A., Stenager, E., & Stenager, E. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1549990 · Cited by 6 · see citing works
Coping Strategies and Posttraumatic Growth Following Transient Ischemic Attack: A Qualitative Study
Kindermann, D., Grosse-Holz, V. M., Andermann, M., Ringleb, P. A., Friederich, H., Rizos, T., & Nikendei, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12020575 · Cited by 7 · see citing works
Kasbi, N. A., Ezabadi, S. G., Kohandel, K., Khodaie, F., Sahraian, A. H., Bahrami, S. N., Mohammadi, M., Almasi‐Hashiani, A., Eskandarieh, S., & Sahraian, M. A. (2024) · BMC Neurology · doi:10.1186/s12883-024-03815-9 · Cited by 7 · see citing works
Gender-affirming interventions and prognosis in multiple sclerosis
Neyal, N., Nathoo, N., Cathcart-Rake, E. J., Kantarci, O. H., & Zeydan, B. (2025) · Multiple Sclerosis Journal · doi:10.1177/13524585251341174 · Cited by 7 · see citing works
Israel‐Elgali, I., Pan, H., Oved, K., Pillar, N., Levy, G., Barak, B., Carneiro, A. M. D., Gurwitz, D., & Shomron, N. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.09.012 · Cited by 7 · see citing works
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. P. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_76 · Cited by 7 · see citing works
Psychische Störungen bei somatischen Krankheiten
Kapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_88 · Cited by 6 · see citing works
Dahham, J., Hiligsmann, M., Kremer, I., Khoury, S. J., Darwish, H., Hosseini, H., Hallit, S. R., Evers, S., & Rizk, R. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105635 · Cited by 6 · see citing works
Psychiatric Disorders, Stress, and Their Treatment Among People with Multiple Sclerosis
Mohr, D. C. (2011) · Springer eBooks · doi:10.1007/978-1-4419-0029-6_8 · Cited by 6 · see citing works
Soltani, E., Izadi, S., Sharifi, P., & Poursadeghfard, M. (2022) · Iranian Journal of Psychiatry and Behavioral Sciences · doi:10.5812/ijpbs.113524 · Cited by 5 · see citing works
Bacaro, V., Buonanno, C., Mancini, F., & Baglioni, C. (2021) · Journal of Behavioral and Cognitive Therapy · doi:10.1016/j.jbct.2020.12.001 · Cited by 5 · see citing works
Derakhshani, N., Aghdash, S. A., Ghojazadeh, M., Naghavi‐Behzad, M., Asl, V. P., & Samei, B. (2019) · International Archives of Health Sciences · doi:10.4103/iahs.iahs_9_19 · Cited by 5 · see citing works
The Role of Mindfulness in Neurorehabilitation: From the Monastery to the Clinic
Smart, C. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-14895-9_34 · Cited by 5 · see citing works
Manic episode in patient with bipolar disorder and recent multiple sclerosis diagnosis
Yang, S., & Wichser, L. M. H. (2020) · Medicine · doi:10.1097/md.0000000000022823 · Cited by 5 · see citing works
Tardo, L. M., McCreary, M., Majeed, H., & Greenberg, B. M. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221098143 · Cited by 5 · see citing works
Optimizing Outcomes in Multiple Sclerosis – A Consensus Initiative
Coyle, P. K., Arnason, B. G. W., Hurwitz, B. J., & LUBLIN, F. D. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508101134 · Cited by 5 · see citing works
Kapfhammer, H. (2014) · Neuropsychiatrie · doi:10.1007/s40211-014-0105-y · Cited by 4 · see citing works
Buono, V. L., Corallo, F., Bonanno, L., Pria, D., Cara, M. D., Palmeri, R., D’Aleo, G., Rifici, C., Sessa, E., Marino, S., et al. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.105051 · Cited by 4 · see citing works
Iosipchuk, O., Wylie, G. R., Motl, R. W., & Sandroff, B. M. (2025) · International Journal of MS Care · doi:10.7224/1537-2073.2024-003 · Cited by 4 · see citing works
Renal disease associated with multiple sclerosis: A narrative review
Elendu, C., Amaechi, D. C., Elendu, T. C., Ozigis, M. O., Adegbola, M. O., Adebayo, M., & Afolabi, O. G. (2024) · Medicine · doi:10.1097/md.0000000000038222 · Cited by 4 · see citing works
Neves, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804042-3.00047-6 · Cited by 4 · see citing works
Alipor, A., Ali, S. M., Mahnaz, A. D., & Marzieh, H. A. (2011) · Cited by 4 · see citing works
Symptom Management in Multiple Sclerosis
Ben‐Zacharia, A. B., & Mathewson, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-40628-2_6 · Cited by 4 · see citing works
Psychotherapy in Neurorehabilitation
Schmidt, R., Piliavska, K., Maier-Ring, D., van Husen, D. K., & Dettmers, C. (2017) · Neurology International Open · doi:10.1055/s-0043-104643 · Cited by 4 · see citing works
Differences in Prescription Drug Misuse Among U.S. Adults With and Without Disabilities
Garcia, J. M., Ross, S. M., & Haegele, J. A. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.01.025 · Cited by 3 · see citing works
- Authors
- Chwastiak, L. A., & Ehde, D. M.
- Affiliations
- Yale University (US)
- University of Washington (US)
- Corresponding author
- Chwastiak, Lydia A.
- Venue
- Psychiatric Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2007-12
- Volume
- 30
- Issue
- 4
- Pages
- 803-817
- ISSN
- 0193-953X (ISSN-L)
- PMC
- PMC2706287
- OpenAlex
- W2128234760
- Cited by
- 166
- References
- 101
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 9 · 2023: 14 · 2022: 8 · 2021: 16 · 2020: 5 · 2019: 9 · 2018: 14 · 2017: 11 · 2016: 10 · 2015: 11 · 2014: 6 · 2013: 8 · 2012: 6
- FWCI
- 0.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Psychiatric Clinics of North America (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K23MH077824)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- multiple sclerosis, major depressive disorder, anxiety disorders, psychiatric comorbidity, medication adherence, quality of life, pharmacotherapy side effects, substance use disorders, bipolar disorder, schizophrenia, underdiagnosis of depression
- MeSH terms
- Mental Disorders, Diagnosis, Differential, Humans, Multiple Sclerosis, Quality of Life, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review